Ridner Sheila H
Vanderbilt University School of Nursing, 461 21st Ave. South, Nashville, TN 37240, USA.
Patient Educ Couns. 2006 Apr;61(1):72-9. doi: 10.1016/j.pec.2005.02.009.
In 1998, the American Cancer Society (ACS) Lymphedema Workshop, called for a three phase approach to patient lymphedema education: (1) pretreatment, (2) postoperatively, and (3) continuing education. The objectives of this study were: to compare recalled pretreatment lymphedema education before and after the 1998 ACS call; compare recalled lymphedema pretreatment education between women with and without breast cancer treatment-related lymphedema; and identify breast cancer survivors perceived sources of lymphedema education.
One hundred and forty-nine breast cancer survivors (74 with lymphedema and 75 without lymphedema) were asked: (1) Prior to having breast cancer treatment did anyone talk to you about your risk for lymphedema? If yes, who? (2) Prior to having breast cancer treatment did anyone talk to you about ways to decrease your risk for lymphedema? If yes, who? (3) If you want to learn more about lymphedema occurring after breast cancer treatment who would you ask or where would you look for information?
Individuals with lymphedema consistently recalled receiving less education and a decline in recalled risk reduction education in the lymphedema group occurred after 1998.
Barriers exist to the integration of ACS suggested pretreatment lymphedema educational protocols and risk reduction education may influence risk of developing lymphedema.
Pretreatment lymphedema education may improve breast cancer survivor's recall of educational information received about lymphedema.
Healthcare providers must be well versed about breast cancer treatment-related lymphedema and communicate this knowledge to patients on a consistent basis.
1998年,美国癌症协会(ACS)淋巴水肿研讨会呼吁采用三阶段方法对患者进行淋巴水肿教育:(1)治疗前,(2)术后,以及(3)继续教育。本研究的目的是:比较1998年美国癌症协会呼吁前后患者回忆起的治疗前淋巴水肿教育情况;比较有和没有乳腺癌治疗相关淋巴水肿的女性之间回忆起的淋巴水肿治疗前教育情况;并确定乳腺癌幸存者认为的淋巴水肿教育来源。
询问了149名乳腺癌幸存者(74名有淋巴水肿,75名无淋巴水肿):(1)在进行乳腺癌治疗之前,有没有人跟你谈过你患淋巴水肿的风险?如果有,是谁?(2)在进行乳腺癌治疗之前,有没有人跟你谈过降低患淋巴水肿风险的方法?如果有,是谁?(3)如果你想了解更多关于乳腺癌治疗后发生淋巴水肿的信息,你会问谁或在哪里寻找信息?
淋巴水肿患者一直回忆起接受的教育较少,并且1998年后淋巴水肿组中回忆起的降低风险教育有所下降。
美国癌症协会建议的治疗前淋巴水肿教育方案的整合存在障碍,降低风险教育可能会影响发生淋巴水肿的风险。
治疗前淋巴水肿教育可能会改善乳腺癌幸存者对所接受的关于淋巴水肿的教育信息的回忆。
医疗保健提供者必须精通乳腺癌治疗相关的淋巴水肿,并持续地将这些知识传达给患者。